ArticleFrontiers in public health2025
The epidemiology and burden of respiratory syncytial virus and influenza infections in hospitalized children under 5 years old in Zhejiang, China (2018-2023).
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Management cost of respiratory syncytial virus-associated hospitalisation episodes in children: a retrospective analysis of a regionally representative medical database in Eastern China.Journal of global health · 2026Article
- Hospitalized children with influenza virus: a 17 year-long observational study including the 2009 H1N1 influenza pandemic and COVID-19 pandemic.BMC infectious diseases · 2026Observational
- Comparative analysis of influenza epidemiological characteristics in Quzhou, China from 2016 to 2024.Annals of medicine · 2025Article
- Post-pandemic resurgence of respiratory virus infections: age and department-specific patterns in a Chinese tertiary hospital (2020-2024).BMC infectious diseases · 2025Article
- Respiratory syncytial virus hospitalization costs, rates, and seasonality in Asia: a systematic review and meta-analysis.EClinicalMedicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Estimate changes in hospital-based respiratory syncytial virus (RSV) disease burden before and after the COVID-19 pandemic and compare this burden with influenza among children younger than 5 years old in China's Zhejiang Province. Methods: We enrolled hospitalized children under 5 years old from eight hospitals in Zhejiang Province. Multiple testing methods were used to compare epidemiological characteristics, and multivariate logistic regression analyses were used to estimate the odds ratio (OR) and 95% confidence interval (CI) between the two groups. Results: In this study, of the 7,857 RSV and 2,571 influenza patients, the median age of the children was significantly lower for RSV infection than for influenza. Inpatients with RSV had longer hospitalization durations (mean: 5.66 days vs. 5.04 days; Conclusion: RSV is a significant contributor to disease burden in hospitalized children under 5 years old, outweighing influenza. The COVID-19 pandemic impacted the epidemiological characteristics and disease burden of hospitalization for RSV and influenza infections. A more effective prevention strategy for both infections in young children, especially vaccinations against RSV and influenza, is urged.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.